UBS Group’s Arcosa ACA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $7.86M | Sell |
54,084
-32,369
| -37% | -$4.02M | ﹤0.01% | 3708 |
|
|
2026
Q1 | $9.18M | Buy |
86,453
+32,205
| +59% | +$3.66M | ﹤0.01% | 3456 |
|
|
2025
Q4 | $5.77M | Sell |
54,248
-4,408
| -8% | -$445K | ﹤0.01% | 3885 |
|
|
2025
Q3 | $5.5M | Buy |
58,656
+3,955
| +7% | +$368K | ﹤0.01% | 3936 |
|
|
2025
Q2 | $4.74M | Sell |
54,701
-32,068
| -37% | -$2.68M | ﹤0.01% | 3949 |
|
|
2025
Q1 | $6.69M | Buy |
86,769
+23,707
| +38% | +$2.17M | ﹤0.01% | 3483 |
|
|
2024
Q4 | $6.1M | Buy |
63,062
+25,034
| +66% | +$2.52M | ﹤0.01% | 3602 |
|
|
2024
Q3 | $3.6M | Sell |
38,028
-23,592
| -38% | -$2.06M | ﹤0.01% | 3402 |
|
|
2024
Q2 | $5.14M | Buy |
61,620
+8,333
| +16% | +$694K | ﹤0.01% | 2851 |
|
|
2024
Q1 | $4.58M | Sell |
53,287
-5,532
| -9% | -$450K | ﹤0.01% | 3066 |
|
|
2023
Q4 | $4.86M | Buy |
58,819
+28,868
| +96% | +$2.12M | ﹤0.01% | 2812 |
|
|
2023
Q3 | $2.15M | Sell |
29,951
-19,961
| -40% | -$1.51M | ﹤0.01% | 3372 |
|
|
2023
Q2 | $3.78M | Buy |
49,912
+15,742
| +46% | +$1.06M | ﹤0.01% | 2862 |
|
|
2023
Q1 | $2.16M | Buy |
34,170
+2,872
| +9% | +$169K | ﹤0.01% | 3344 |
|
|
2022
Q4 | $1.7M | Buy |
31,298
+17,364
| +125% | +$1.03M | ﹤0.01% | 3547 |
|
|
2022
Q3 | $797K | Buy |
13,934
+7,594
| +120% | +$421K | ﹤0.01% | 3944 |
|
|
2022
Q2 | $294K | Sell |
6,340
-17,438
| -73% | -$914K | ﹤0.01% | 4640 |
|
|
2022
Q1 | $1.36M | Sell |
23,778
-8,474
| -26% | -$437K | ﹤0.01% | 3807 |
|
|
2021
Q4 | $1.7M | Buy |
32,252
+15,697
| +95% | +$839K | ﹤0.01% | 3884 |
|
|
2021
Q3 | $831K | Sell |
16,555
-7,991
| -33% | -$414K | ﹤0.01% | 4345 |
|
|
2021
Q2 | $1.44M | Sell |
24,546
-5,426
| -18% | -$336K | ﹤0.01% | 3865 |
|
|
2021
Q1 | $1.95M | Sell |
29,972
-49,494
| -62% | -$3.04M | ﹤0.01% | 3585 |
|
|
2020
Q4 | $4.37M | Sell |
79,466
-6,545
| -8% | -$334K | ﹤0.01% | 2596 |
|
|
2020
Q3 | $3.79M | Buy |
86,011
+42,482
| +98% | +$1.87M | ﹤0.01% | 2455 |
|
|
2020
Q2 | $1.84M | Sell |
43,529
-66,671
| -61% | -$2.56M | ﹤0.01% | 2958 |
|
|
2020
Q1 | $4.38M | Buy |
110,200
+41,062
| +59% | +$1.74M | ﹤0.01% | 2040 |
|
|
2019
Q4 | $3.08M | Sell |
69,138
-34,012
| -33% | -$1.31M | ﹤0.01% | 3104 |
|
|
2019
Q3 | $3.53M | Buy |
103,150
+6,173
| +6% | +$214K | ﹤0.01% | 2719 |
|
|
2019
Q2 | $3.65M | Buy |
96,977
+20,252
| +26% | +$693K | ﹤0.01% | 2594 |
|
|
2019
Q1 | $2.34M | Buy |
76,725
+1,482
| +2% | +$45.3K | ﹤0.01% | 2851 |
|
|
2018
Q4 | $2.08M | Buy |
+75,243
| New | +$2.07M | ﹤0.01% | 2997 |
|
Other funds holding ACA
NAMI
RA
UBS Group's ACA Position: Q2 2026 in Review
UBS Group reduced its Arcosa (ACA) stake by 37% in Q2 2026, selling an estimated $4.02M and leaving 54,084 shares worth $7.86M. The position accounts for ﹤0.01% of the portfolio, ranked #3708.
UBS Group first reported a position in ACA in Q4 2018 and has held it in 31 quarters since. The position peaked at $9.18M in Q1 2026. 425 funds tracked by Wall St. Rank hold ACA as of Q2 2026.
- UBS Group held 54,084 shares of Arcosa worth $7.86M as of Q2 2026.
- UBS Group sold 32,369 Arcosa shares in Q2 2026, an estimated $4.02M.
- Arcosa made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #3708 holding.
- UBS Group first reported a position in Arcosa in Q4 2018 and has held it in 31 quarters since.
- UBS Group's Arcosa position peaked at $9.18M in Q1 2026.
- 425 funds tracked by Wall St. Rank held Arcosa as of Q2 2026.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.